-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

908. Outcomes Research: Myeloid Malignancies: Poster III

Symposia: Outcomes Research: Myeloid Malignancies Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Shai O. Shimony, MD1, Yating Wang, MS2*, Angel Cronin, MS2*, Thomas P Walsh1*, Anne Charles1*, Natalie Slopen, PhD3*, Maximilian Stahl, MD4, Rebecca P. Bystrom, MD1,5, Marlise R. Luskin, MD1, Gregory Abel, MD, MPH1, Daniel J. DeAngelo, MD, PhD1, Richard M Stone, MD1, R. Coleman Lindsley, MD6 and Andrew Hantel, MD1

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
3Harvard School of Public Health, Boston, MA
4Dana Farber Cancer Institute, Boston, MA
5NHLBI / NCI, National Institutes of Health, Bethesda, MD
6Dana-Farber Cancer Institute, Boston, MA

Rachel Gorham, MD1*, Reena V. Jayani, MD, MSCI2, Christina Snider, MD1, Chiu-Lan Chen, PhD3*, Adetola A. Kassim, MD, MBBS, MS2,4, Bipin N. Savani, MD2,4, Wichai Chinratanalab, MD4*, Bhagirathbhai R. Dholaria, MBBS3,4, Tae Kon Kim, MD4, Olalekan O. Oluwole, MD, MPH, MBBS2, Andrew P Jallouk, MD, PhD2, Eden Ayele Biltibo, MD, MS3, James H. Jerkins, MD2* and Salyka Sengsayadeth, MD4*

1Internal Medicine, Vanderbilt University Medical Center, Nashville, TN
2Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
3Vanderbilt University Medical Center, Nashville, TN
4Tennessee Valley Healthcare System Veteran Affairs, Nashville, TN

Kristine Broge-Reynen, NP1*, Emily Giever, MSN, RN2*, Aniko Szabo, PhD3*, Ryan Conrardy3*, Nicole M Held, DO4, Laura C. Michaelis, MD5,6, Lyndsey Runaas, MD7*, Sameem Abedin, MD4,8, Guru Subramanian Guru Murthy, MBBS3, Karen-Sue Carlson, MD, PhD9,10, Ravi Kishore Narra, MD, MS11, Sumana Devata, MD3, Sheila Swartz, MD, MPH12*, Valarie Ehrlich, PA-C9*, Mary Rodgers, MSN, APNP, AGACNP-BC9*, Allison Johnson, MSN, DNP, AGACNP-BC9* and Ehab L. Atallah, MD6

1Division of Hematology and Oncology, Medical College of Wisconsin, New Berlin, WI
2Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
3Medical College of Wisconsin, Milwaukee, WI
4Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
5Division of Hematology/Oncology, Department of Medicine, The Medical College of Wisconsin Inc, Milwaukee, WI
6Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
7Medical College of Wisconsin, Division of Hematology/Oncology, Milwaukee, WI
8CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
9Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
10Versiti Blood Research Institute, Milwaukee, WI
11Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
12Department of Hospital Medicine, Medical College of Wisconsin, Milwaukee, WI

Angela M. Canadeo, PharmD1*, Emily Giever, MSN, RN2*, Aniko Szabo, PhD3*, Yuchen Jin3*, Eric S. Winer, MD4, Talha Badar, MD5, Jaclynn Campos, PA-C6*, Chenyu Lin, MD7, Clare E Anderson, MD8*, Rory M. Shallis, MD9, Tinatin Muradashvili, MD10*, Alexander Coltoff, MD11, Qi Jin Guo, MD12*, Anand Ashwin Patel, MD13, Leah A Goldberg, MD14*, Yasmin Abaza, MD15, Maaridge Fariduddin, MABS15*, Rauna Ayoub, MABS15*, Charles Foucar, MD16, Nhi Nai, DO17*, Vamsi K. Kota, MD18, Mark Dalgetty, DO19*, Matthew Gold, DO20*, Medha Guduru21* and Ehab L. Atallah, MD22

1Froedtert & Medical College of Wisconsin, Milwaukee, WI
2Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
3Medical College of Wisconsin, Milwaukee, WI
4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
5Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
6Mayo Clinic Cancer Center, Jacksonville, FL
7Duke Cancer Institute, Duke University School of Medicine, Durham, NC
8Department of Medicine, Duke University School of Medicine, Durham, NC
9Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, Killingworth, CT
10Department of Hematology, Yale University, Cliffside Park, NJ
11Medical University of South Carolina, Charleston, SC
12Medical University of South Carolina (MUSC), Charleston, SC
13Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
14Department of Internal Medicine, University of Chicago Medical Center, Chicago, IL
15Northwestern University, Chicago, IL
16University of New Mexico School of Medicine, Albuquerque, NM
17University of New Mexico, Albuquerque, NM
18Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, GA
19Georgia Cancer Center, Augusta, GA
20Medical College of Georgia, Augusta, GA
21Medical College of Georiga, Augusta, GA
22Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI

Josh Zhang, PharmD1*, Shai O. Shimony, MD2, Yiwen Liu, MS3*, Eno Inyang, PharmD1*, Evan C. Chen, MD4, Luis E. Aguirre, MD4, Rebecca P. Bystrom, MD4, Benjamin Rolles, MD4, Richard M. Stone, MD5, Daniel J. DeAngelo, MD, PhD2, Emily Tiao, PharmD1* and Maximilian Stahl, MD2

1Department of Pharmacy, Dana-Farber Cancer Institute, Boston, MA
2Adult Leukemia Program, Dana-Farber Cancer Institute, Boston, MA
3Data Science, Dana-Farber Cancer Institute, Boston, MA
4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
5Dana-Farber Cancer Institute, Boston, MA

Albert Ekow Orhin1*, Albert Gyato, MBCHB2*, Albert Ohene, MBCHB3*, Samuel Darlynton Otoo, MBCHB4*, Fiifi Assabill, MBCHB5*, Natalie Atese Yaa Akoto, MD, MPH6* and Dipen Khanapara, MD7

1Molecular Microbiology and Immunology, Johns Hopkins University, Towson, MD
2Internal Medicine, University of Ghana Medical Centre, Accra, Ghana
3Tetteh Quarshie Memorial Hospital, Mampong, Ghana
4Korle Bu Teaching Hospital, Accra, Ghana
5Bibiani Hospital, Bibiani, Ghana
6Internal Medicine, Medstar Union Memorial Hospital, Baltimore
7University of Cincinnati, Cincinnati, OH

Steven Tessier, MD, MS

Mayo Clinic, Rochester, MN

Ayobami Olafimihan, MBBS1, Inimfon Jackson, MD, PhD, MPH2, Khaldun Obeidat, MD3, Youjin Oh, MD4*, Dawid Mehlich, MD, PhD5*, Praise Fawehinmi6* and Hafeez Shaka, MD7*

1John H. Stroger Jr. Hospital of Cook County, Chicago, IL
2The University of Texas MD Anderson Cancer Center, Houston, TX
3University of Wisconsin, Madison, WI
4John H. Stroger Jr. Hospital of Cook County, Chicago
5Medicine, John H. Stroger Jr. Hospital of Cook County, Chicago, IL
6Southern Illinois University Edwardsville, Edwardsville
7John H. Stroger Hospital of Cook County, Chicago, IL

Dennis Lund Hansen, MD, PhD1*, Tine Bichel Lauritsen, MD, PhD2*, Jan M Norgaard, MD, PhD, DMSc2, Susanne Dalton, MD, DMSc, Prof3,4*, Kirsten Gronbaek, MD, PhD, PR5,6, Tarec Christoffer El-Galaly, MD, DMSc, Prof1,7,8 and Lene Sofie Granfeldt Østgård1,9*

1Department of Hematology, Odense University Hospital, Odense, Denmark
2Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
3Cancer Survivorship, Danish Cancer Institute, Danish Cancer Society Research Center, Copenhagen, Denmark
4Department of Clinical Oncology and Palliative Care, Zealand University Hospital, Næstved, Denmark
5Rigshospitalet, University of Copenhagen, Copenhagen N, Denmark
6Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
7Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
8Department of Hematology, Aalborg Hospital, Aalborg, Denmark
9Aarhus University Hospital, Department of Clinical Epidemiology, Aarhus, Denmark

Diego Adrianzen Herrera, MD, MSc1, Andrew Sparks, MS2*, Aneta Strumilowska1* and Neil Zakai1

1Larner College of Medicine at the University of Vermont, Burlington, VT
2Biomedical Statistics Research Core at the University of Vermont, Burlington, VT

Luiza Perruso, MD1*, Abel Costa Neto, MD1, Wellington F. Silva, MD, PhD2, Marina Nascimento, MD3*, Yana S Rabelo, MD4*, Ederson Roberto Mattos, MD5*, Fernanda R. Mendes, MD6*, Juliana Martins, MD7*, Verena Pfister8*, Maria Daniela Holthausen Perico, MD9*, Carlos Chiattone, MD, PhD10 and Eduardo M. Rego, MD, PhD7,11

1Hematology, D`Or Institute for Research and Education, São Paulo, Brazil
2Division of Hematology, Instituto do Cancer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil
3A.C. CAMARGO CANCER CENTER, Sao Paulo, BRA
4Goias Federal University, Goias, Brazil
5Hospital Amaral Carvalho, Jau, BRA
6Division of Hematology, Instituto do Cancer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
7D'Or Institute for Research and Education, Sao Paulo, Brazil
8Division of Hematology - UNIFESP, Sao Paulo, AC, Brazil
9Centro de Hematologia e Hemoterapia de Santa Catarina – HEMOSC - Fundação de Apoio ao Hemosc / Cepon –, Florianopolia, Brazil
10Hospital Samaritano-Higienopolis, Sao Paulo, Brazil
11Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, University of São Paulo Medical School, Sao Paulo, Brazil

Dahniel L Sastow, MD1, Daniel I. Nathan, MD2, Hannah Levavi, MD3, Jonathan Feld, MD1 and Douglas Tremblay, MD1

1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2Division of Hematology & Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
3Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Brooklyn, NY

Natalie S. Rosen, MD1, Shikun Wang, PhD1*, Joseph G Jurcic, MD1, Justine M. Kahn, MD, MSc2 and Aaron D. Viny, MD, MS3

1Herbert Irving Comprehensive Cancer Center and Columbia University Irving Medical Center, New York, NY
2Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY
3Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY

Hung-Lun Chien1*, Craig Zimmerman, PhD2*, Andrew Howe, PharmD3*, Robert Geller, MD4* and Albert Qin, MD, PhD5*

1PharmaEssentia, Burlington, MA
2PharmaEssentia U.S.A. Corp., Burlington, MA
335 Corporate Dr, Suite 325, PharmaEssentia USA Corporation, Burlington, MA
4PharmaEssentia USA Corporation, Burlington, MA
5Medical Research & Clinical Operations, PharmaEssentia Corporation, Taipei, Taiwan

Kelly Schoenbeck, MD1, Isabelle Vu2*, Albert Lee3*, Mansa Devaki4*, Insiyah Merchant5*, Faaiz Ibrahim6*, Anand Dhruva, MD7,8*, Catherine C. Smith, MD9, Neil P. Shah, MD, PhD5 and Chloe Atreya, MD PhD7,8*

1Division of Hematology and Oncology, University of California San Francisco, SAN FRANCISCO, CA
2School of Medicine, University of California San Francisco, San Francisco, CA
3School of Medicine, University of California San Diego, San Diego, CA
4University of California Berkeley, Berkeley, CA
5University of California San Francisco, San Francisco, CA
6Touro University California, Vallejo, CA
7Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA
8Osher Center for Integrative Health, University of California San Francisco, San Francisco, CA
9Department of Medicine, Division of Hematology/Oncology, University of California, San Francisco, San Francisco, CA

Muhammad Faisal Aslam1*, Muhammad Hisham Khan Wazir, MD2*, Asfand Yar Cheema, MD3* and Omer Jamy, MD4

1Ascension St. Vincent’s Hospital, Birmingham, AL
2Montefiore St. Luke's, Newburgh, NY
3Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
4O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, AL

Meinolf Karthaus, MD1, Michael G. Kiehl, MD2, Ilana Reinhold3*, Oliver A. Cornely3* and Jannik Stemler3*

1MVZ Perlach OnkoMedeor, Muenchen, Germany
2Med. Klinik, Rhoen-Klinikum Frankfurt/Oder, Frankfurt, Germany
3Department I of Internal Medicine, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany

Rosa Greco1*, Silvia Imbergamo2*, Elisabetta Pierdomenico3*, Barbara Di Camillo4*, Cristina Papayannidis, MD, PhD5, Elisabetta Todisco6*, Erika Borlenghi, MD7*, Nicola Fracchiolla8*, Claudia Basilico9*, Monica Fumagalli, MD10*, Patrizia Zappasodi11*, Mauro Turrini, MD12*, Anna Candoni13*, Monia Lunghi14*, Maurizio Musso15*, Calogero Vetro, MD16*, Fabio Guolo, MD, PhD17, Donato Mannina18*, Albana Lico19*, Anna Maria Scattolin20*, Gianpaolo Nadali21*, Monica Crugnola, MD22*, Sara Galimberti, MD23*, Francesco Marchesi24*, Elisabetta Metafuni25*, Tommaso Caravita di Toritto26*, Clara Minotti27*, Pellegrino Musto28*, Valentina Mancini, MD29*, Marta Riva29*, Lorenzo Rizzo29*, Giovanni Grillo30* and Roberto Cairoli, MD29*

1Hematology Unit, ASST GOM Niguarda, Milano, ITA
2Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy
3Hematology Unit, IOV IRCCS, sede di Castelfranco Veneto, Castelfranco Veneto, Castelfranco Veneto, Italy
4Department of Information Engineering, University of Padova, Padova, Italy
5IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
6Hematology, ASST Valle Olona, Ospedale di Busto Arsizio, Busto Arsizio, Italy
7ASST Spedali Civili, Brescia, Department of Hematology, Brescia, Italy
8Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
9Hematology Unit, ASST Sette Laghi-Ospedale di Circolo di Varese e Fondazione Macchi, Varese, Italy
10Hematology Division and Bone Marrow Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
11Hematology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
12Hematology Unit, Division of Hematology, Valduce Hospital, Como, Como, Italy
13Hematology Unit, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC), Udine, Italy
14Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
15Hematology Unit, Clinica La Maddalena Division of Onco-Hematology and Stem Cell Transplantation, Palermo, Italy
16Division of hematology, A.O.U. Policlinico G.Rodolico – S. Marco, Catania, Italy
17Hematology Unit, Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy
18Hematology Unit, Messina - Azienda Ospedali Riuniti Papardo-Piemonte - S.C. Ematologia, Messina, ITA
19Hematology Unit, Hematology Unit, San Bortolo Hospital, Vicenza, Italy, Vicenza, Italy
20Hematology Unit, Ospedale Dell Angelo, Mestre, ITA
21Hematology Unit, Azienda Ospedaliera Di Verona, Verona, ITA
22Hematology Unit, University of Parma, Parma, Italy
23Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy
24Hematology and Stem Cell Transplant Unit, IRCCS - Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri (I.F.O.), Rome, Italy
25Hematology Unit, Università Cattolica Del Sacro Cuore, Rome, ITA
26Hematology Unit, Ematologia, Ospedale Santo Spirito ASL Roma1, Roma, ITA
27Department of Translational and Precision Medicine, Division of Hematology, Sapienza University, Rome, Italy
28Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine,and Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Bari, Italy
29Department of Hematology and Oncology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
30Department of Hematology and Stem Cell Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

Amer M. Zeidan, MD1, Ruizhi Zhao, PhD2*, Dudith Pierre-Victor, PhD, MPH3*, Yuexi Wang, ME3*, Jon Tepsick, MS3*, Ziyu Lan, MPH3* and Tehseen Salimi, MD, MHA2*

1Yale School of Medicine, Smilow Cancer Hospital at Yale New Haven, New Haven, CT
2Taiho Oncology, Inc., Princeton, NJ
3ConcertAI, LLC, Cambridge, MA

Fatima Tuz Zahra, MBBS1, Faustine Ong, MD2*, Moazzam Shahzad, MD2, Onyee Chan, MD3*, Najla H. Al Ali, Ms4*, Jeffrey E Lancet, MD4, Alison R. Walker, MD, MBA, MPH5, David Sallman, MD4, Rami S. Komrokji, MD4, Seongseok Yun, MD, PhD4, Andrew T. Kuykendall, MD4, Eric Padron, MD4 and Zhuoer Xie, MD, MS4

1Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, ALBANY, NY
2Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
3H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Wesley Chapel, FL

Joshua A. Roth, PhD1*, Paul G D'Amico, PhD, NP, RN2, Alexander Russell-Smith, MSc3*, Simon Purcell, MPharm4*, Elizabeth Donckels, MSPH5*, Joseph C. Cappelleri, PhD6*, Jia Ma, PhD2*, Allison Petrilla, MPH5*, Jerry Kagan5* and Anthony Yu, PharmD, MS5*

1Pfizer, Seattle, WA
2Pfizer, New York, NY
3Pfizer R&D UK Ltd, Sandwich, GBR
4Pfizer, Sandwich, United Kingdom
5Inovalon, Bowie, MD
6Pfizer Inc, Groton, CT

Gaurav Vadnerkar, PhD1*, Joan Clements, AA, ABA2*, Mel Mann, MBA, M.Ed.3*, Vainavika Reddy Gaddam, MBA4*, Chaitali Nag, MSc4*, Shiva Padhi, MBA4*, David Wei, PhD1*, Marcello Azolino, MBA1*, Kejal Jadhav, B.Pharm, MS1*, Daisy Yang, PharmD, BCOP1*, Andrea Damon, PhD1* and Islam Sadek, MD1

1Novartis Pharmaceuticals Corporation, East Hanover, NJ
2CML Buster Foundation, Costa Mesa, CA
3Magnolia Crest, Jonesboro, GA
4Novartis Healthcare Private Limited, Hyderabad, India

Akhil Rajendra, MD, MBBS, DM1, Elliot Smith, MD2*, Eshetu Atenafu, M.Sc, P. Stat3*, Aniket Bankar, MD, MBBS, MSc, DM4, Steven M. Chan, MD, PhD5, Marta Beata Davidson, MD, PhD4, Vikas Gupta, MD, FRCP, FRCPath6, Mark D. Minden, MD, PhD7*, Maria Agustina Perusini8, Guillaume Richard-Carpentier, MD, FRCPC9, Aaron D Schimmer, MD10, Andre C. Schuh, MD, FRCPC7, Hassan Sibai, MD7, Karen Yee, MD, FRCPC7* and Dawn C. Maze, MD, FRCPC, MSc7

1Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada
2Department of Medicine, University of Toronto, Toronto, ON, Canada
3Biostatistics, University Health Network, Toronto, Canada
4Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada
5Princess Margaret Cancer Centre, Toronto, ON, Canada
6The Princess Margaret Cancer Centre, Toronto, ON, Canada
7Princess Margaret Cancer Centre / University Health Network, Toronto, ON, Canada
8Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
9Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
10Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

Zalak Shah, MD1, Danielle Boselli, MS2*, Stephanie Begley, MS2*, Rupali Bose, MS, MBA2*, Yifan Pang, MD3, Srinivasa Reddy Sanikommu, MD3, Nilay A. Shah, MD3*, Aleksander L. Chojecki, MD3, Thomas G. Knight, MD3, Jing Ai, MD, PhD3, Belinda Avalos, MD3, Edward A. Copelan, MD3, Michael R. Grunwald, MD3 and Brittany Knick Ragon, MD3

1Atrium Health Levine Cancer Institute, Charlotte, NC
2Department of Biostatistics and Data Sciences, Atrium Health Levine Cancer Institute, Charlotte, NC
3Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC

Muhammad Ali Khan, MBBS1*, Syed Arsalan Naqvi, MBBS1*, Cecilia Y. Arana Yi, MD2, John Camoriano, MD3*, Joshua Blocher4*, Jennifer Andres4*, Irbaz Bin Riaz, MD, MMSc1* and Jeanne Palmer, MD5

1Mayo Clinic, Phoenix, AZ
2Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ
3Mayo Clinic Scottsdale, Scottsdale, AZ
4Mayo Clinic, Phoenix
5Mayo Clinic - Arizona, Scottsdale, AZ

Manuel David Gil-Sierra1*, Theo Mantopoulos2*, Ifigeneia Barouma3*, Ole Hauch4*, Zhaoyang Teng5*, Cedric Fernandez6*, Sean Corbet6* and Max Schlueter7*

1Andalusian Health Service, Sevilla, Spain
2IQVIA, Koropi Attikis, WY, Greece
3IQVIA, Athens, Greece
4Servier pharmaceuticals, Bruxelles, Belgium
5Servier pharmaceuticals, Boston
6Servier pharmaceuticals, Suresnes, France
7IQVIA, London, United Kingdom

Sadia Ansar1*, Mahnoor Asghar Keen, MD, MBBS2*, Mahnoor Sukaina, MBBS3*, Muhammad Saeed, MBBS4*, Zarlish Rehman, MD, MBBS2*, Roshaan Rehman, MBBS5*, Qazi Muhammad Farooq Wahab, MD, MBBS2*, Faryal Masaud, MBBS2*, Aqsa Mumtaz, MD, MBBS6*, Karan Jatwani, MD, MBBS7* and Muhammad Salman Faisal, MD, MBBS8

1Rawal Institute of Health Sciences, Islamabad, Pakistan
2Khyber Medical College, Peshawar, Pakistan
3Karachi Medical and Dental College, Karachi, Pakistan
4D.G. Khan Medical College, Dera Ghazi Khan, Pakistan
5Kabir Medical College, Peshawar, Pakistan
6Montefiore St. Luke's Cornwall, Newburgh, NY
7Assistant Professor, Department of Hematology Oncology, George Washington University, Washington DC
8University of Oklahoma Stephenson Cancer Center, Oklahoma City, OK

*signifies non-member of ASH